Distribution of hydrolytic activity catalyzes the biotransformation of prednisolone 21-acetate in human skin

被引:6
作者
Hikima, T [1 ]
Maibach, HI [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2001年 / 14卷 / 04期
关键词
distribution of metabolite; hydrolytic enzyme; basement layer of epidermis; skin slicing technique;
D O I
10.1159/000056347
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We investigated the distribution of hydrolytic enzymes which metabolize prednisolone 21-acetate (PNA) to prednisolone (PN) in human skin. K-m (Michaelis-Menten constant) and V-max (maximum rate) of hydrolytic enzyme in human skin was 25.1 muM and 0.46 nmol/min/ mg protein, respectively. Specific activities of hydrolysis in dermis and epidermis were similar and, in consideration to their thickness, hydrolytic activity in epidermis was 12.1 times higher than in dermis. Moreover, the highest amount of metabolite (PN) was found at 80-120 mum from the skin surface by skin slicing. Therefore, hydrolytic activity which metabolized PNA was distributed in epidermis, especially in the basement membrane area; epidermis borders dermis in this area and the papillary plexus is reached just beneath the dermal papillae. These results suggest that the distribution of hydrolytic activity in human skin may prevent certain substances from entering the systemic circulation in their unhydrolyzed form. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 26 条
[1]   NATURE AND EVOLUTION OF PORT WINE STAINS - COMPUTER-ASSISTED STUDY [J].
BARSKY, SH ;
ROSEN, S ;
GEER, DE ;
NOE, JM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (03) :154-157
[2]   USE OF ANTI-BASEMENT MEMBRANE ANTIBODIES TO DISTINGUISH BLOOD-VESSEL CAPILLARIES FROM LYMPHATIC CAPILLARIES [J].
BARSKY, SH ;
BAKER, A ;
SIEGAL, GP ;
TOGO, S ;
LIOTTA, LA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (07) :667-677
[3]  
BICKERS DR, 1983, MOL PHARMACOL, V21, P239
[4]  
Brookes F.L., 1982, J PHARM PHARMACOL, p61P, DOI [10.1111/j.2042-7158.1982.tb00892.x, DOI 10.1111/J.2042-7158.1982.TB00892.X]
[5]   The 5 alpha-reductase system and its inhibitors - Recent development and its perspective in treating androgen-dependent skin disorders [J].
Chen, W ;
Zouboulis, CC ;
Orfanos, CE .
DERMATOLOGY, 1996, 193 (03) :177-184
[6]   IMMUNOHISTOCHEMICAL EVIDENCE FOR DIFFERENTIAL DISTRIBUTION OF 5-ALPHA-REDUCTASE ISOENZYMES IN HUMAN SKIN [J].
EICHELER, W ;
DREHER, M ;
HOFFMANN, R ;
HAPPLE, R ;
AUMULLER, G .
BRITISH JOURNAL OF DERMATOLOGY, 1995, 133 (03) :371-376
[7]  
ESUMI Y, 1992, JPN PHARMACOL THER, V20, P4421
[8]   DISTRIBUTION AND SUB-CELLULAR LOCALIZATION OF DRUG-METABOLIZING ENZYMES IN THE SKIN [J].
FINNEN, MJ ;
HERDMAN, ML ;
SHUSTER, S .
BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (06) :713-721
[9]  
Gavan N, 1997, SKIN PHARMACOL, V10, P309
[10]   HUMAN KERATINOCYTES SYNTHESIZE, SECRETE, AND DEGRADE ACETYLCHOLINE [J].
GRANDO, SA ;
KIST, DA ;
QI, M ;
DAHL, MV .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (01) :32-36